ELMS STEVE

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 83% 68% 82%
Transactions
11 27% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
ELMS STEVE's trades of ADMA Biologics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-09 2026-03-06
B Purchase
86,610 +44.7%
127.42
US$2,982,674 		86,610 +44.7% 127.42 US$2,982,674
2026-03-09 2026-03-05
B Purchase
82,444 +48.7%
378.86
US$3,567,374 		82,444 +48.7% 378.86 US$3,567,374
2025-06-16 2025-06-16
S Sale
59,017 +44.6%
188.66
US$1,061,406 		59,017 +44.6% 188.66 US$1,061,406
2025-06-16 2025-06-13
S Sale
137,931 -32.8%
20.82
US$2,871,723 		137,931 -32.8% 20.82 US$2,871,723
2025-06-16 2025-06-12
S Sale
92,941 -4.4%
21.69
US$2,015,890 		92,941 -4.4% 21.69 US$2,015,890
2025-06-12 2025-06-12
PrS Proposed sale
425,621
21.87
US$9,308,331 		425,621 21.87 US$9,308,331
2024-12-26 2024-12-23
B Purchase
11,085 +3.5%
3.20
US$35,472 		11,085 +3.5% 3.20 US$35,472
2024-03-19 2024-03-19
S Sale
411,829 -16.3%
6.08
US$2,503,920 		411,829 -16.3% 6.08 US$2,503,920
2024-03-19 2024-03-18
S Sale
49,887 -1.9%
6.01
US$299,821 		49,887 -1.9% 6.01 US$299,821
2024-03-15 2024-03-15
S Sale
183,008 -6.6%
6.01
US$1,099,878 		183,008 -6.6% 6.01 US$1,099,878
2024-03-15 2024-03-14
S Sale
448,276 -14.0%
6.05
US$2,712,070 		448,276 -14.0% 6.05 US$2,712,070
2024-03-15 2024-03-13
S Sale
407,000 -11.3%
6.21
US$2,527,470 		407,000 -11.3% 6.21 US$2,527,470
2021-03-18 2021-03-16
B Purchase
1,142,857 +57.1%
1.75
US$2,000,000 		1,142,857 +57.1% 1.75 US$2,000,000